Patents by Inventor Liangmin Huang

Liangmin Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TROP-2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF
    Publication number: 20250034275
    Abstract: Provided are an anti-TROP-2 antibody or an antigen-binding fragment thereof, a pharmaceutical composition comprising same, and the uses of the anti-TROP-2 antibody or the antigen-binding fragment thereof or the pharmaceutical composition comprising same in the preparation of drugs for cancer treatment.
    Type: Application
    Filed: December 7, 2022
    Publication date: January 30, 2025
    Inventors: Zipeng ZHEN, Liangmin HUANG, Yuanjing MA, Caiyun LV, Zhengping ZHANG
  • Epitope of RSV fusion protein and antibody recognizing the same
    Patent number: 9856313
    Abstract: The present invention relates to an epitope peptide (or a variant thereof) which can be used in the prevention of respiratory syncytial virus (RSV) infection, a recombinant protein comprising the epitope peptide (or a variant thereof) and a carrier protein, and uses of the epitope peptide (or a variant thereof) and the recombinant protein. The present invention also relates to an antibody against the epitope peptide, a cell line for generating the antibody, and uses thereof. Furthermore, the present invention also relates to a vaccine or a pharmaceutical composition comprising the recombinant protein or the antibody according to the invention, for preventing one or more symptoms associated with RSV infection.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: January 2, 2018
    Assignees: XIAMEN UNIVERSITY, XIAMEN INNOVAX BIOTECH CO., LTD., THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Zizheng Zheng, Jason S. McLellan, Man Chen, Min Zhao, Liangmin Huang, Barney S. Graham, Ningshao Xia
  • EPITOPE OF RSV FUSION PROTEIN AND ANTIBODY RECOGNIZING THE SAME
    Publication number: 20160031972
    Abstract: The present invention relates to an epitope peptide (or a variant thereof) which can be used in the prevention of respiratory syncytial virus (RSV) infection, a recombinant protein comprising the epitope peptide (or a variant thereof) and a carrier protein, and uses of the epitope peptide (or a variant thereof) and the recombinant protein. The present invention also relates to an antibody against the epitope peptide, a cell line for generating the antibody, and uses thereof. Furthermore, the present invention also relates to a vaccine or a pharmaceutical composition comprising the recombinant protein or the antibody according to the invention, for preventing one or more symptoms associated with RSV infection.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 4, 2016
    Applicants: XIAMEN INNOVAX BIOTECH CO., LTD., XIAMEN UNIVERSITY
    Inventors: Zizheng Zheng, Jason S. McLellan, Man Chen, Min Zhao, Liangmin Huang, Barney S. Graham, Ningshao Xia